SGLT2 inhibitors for heart failure with reduced ejection fraction: a real EMPEROR?

E Raschi, GP Fadini, I Diemberger… - Expert Opinion on …, 2021 - Taylor & Francis
Introduction: In individuals with type 2 diabetes mellitus, sodium–glucose cotransporter 2
(SGLT2) inhibitors reduce the risk of hospitalization for heart failure and serious adverse …
被引用次数：3 相关文章

SGLT2 inhibitors for heart failure with reduced ejection fraction: a real EMPEROR?

E Raschi, GP Fadini, I Diemberger… - Expert Opinion on …, 2020 - europepmc.org
Introduction: In individuals with type 2 diabetes mellitus, sodium-glucose cotransporter 2
(SGLT2) inhibitors reduce the risk of hospitalization for heart failure and serious adverse …

SGLT2 inhibitors for heart failure with reduced ejection fraction: a real EMPEROR?

E Raschi, GP Fadini, I Diemberger… - EXPERT OPINION …, 2020 - research.unipd.it
Introduction: In individuals with type 2 diabetes mellitus, sodium–glucose cotransporter 2
(SGLT2) inhibitors reduce the risk of hospitalization for heart failure and serious adverse …

SGLT2 inhibitors for heart failure with reduced ejection fraction: a real EMPEROR?

E Raschi, GP Fadini, I Diemberger… - Expert opinion on …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction: In individuals with type 2 diabetes mellitus, sodium-glucose cotransporter 2
(SGLT2) inhibitors reduce the risk of hospitalization for heart failure and serious adverse …

SGLT2 inhibitors for heart failure with reduced ejection fraction: a real EMPEROR?

E Raschi, GP Fadini, I Diemberger, E Poluzzi… - EXPERT OPINION ON …, 2021 - cris.unibo.it
Introduction: In individuals with type 2 diabetes mellitus, sodium–glucose cotransporter 2
(SGLT2) inhibitors reduce the risk of hospitalization for heart failure and serious adverse …